Publications
Bjerke L, Mackay A, Nandhabalan M, Burford A, Jury A, Popov S, Bax DA, Carvalho D, Taylor KR, Vinci M, Bajrami I, McGonnell IM, Lord CJ, Reis RM, Hargrave D, Ashworth A, Workman P, Jones C. Histone H3.3. mutations drive pediatric glioblastoma through upregulation of MYCN. Cancer discovery. 2013. PMID: 23539269
Anish B Bhatt, Claire K Mulvey, Atif N Qasim, Michael R Rickels, Jayamohan Nair, Muredach P Reilly. Abstract 416: Baseline Electrocardiographic Findings Are Associated With Insulin Sensitivity and Beta-Cell Function in Type 2 Diabetes. Arteriosclerosis Thrombosis and Vascular Biology. 2013. PMID:
Catherine C. Smith, Neil P. Shah. The Role of Kinase Inhibitors in the Treatment of Patients with Acute Myeloid Leukemia. American Society of Clinical Oncology Educational Book. 2013. PMID:
Hua-Xin Gao, Valerie Wong, Lingjing Chen, Richard Locksley, Clifford Lowell, James Rubenstein. The roles of tumor associated macrophages and interferon gamma in immune surveillance in CNS lymphoma (P2211). The Journal of Immunology. 2013. PMID:
Gevensleben H, Garcia-Murillas I, Graeser MK, Schiavon G, Osin P, Parton M, Smith IE, Ashworth A, Turner NC. Noninvasive detection of HER2 amplification with plasma DNA digital PCR. Clinical cancer research : an official journal of the American Association for Cancer Research. 2013. PMID: 23637122
Claire K Mulvey, Timothy W Churchill, Karen Terembula, Jane F Ferguson, Nehal N Mehta, Atif N Qasim, Muredach P Reilly. Abstract 84: Serum Amyloid A Does Not Modulate the Inverse Association of HDL with Coronary Artery Calcification in Type 2 Diabetes. Arteriosclerosis Thrombosis and Vascular Biology. 2013. PMID:
Benson AB, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, Engstrom PF, Enzinger PC, Fakih MG, Fenton MJ, Fuchs CS, Grem JL, Hunt S, Kamel A, Leong LA, Lin E, May KS, Mulcahy MF, Murphy K, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Small W, Sofocleous CT, Venook AP, Willett CG, Gregory KM, Freedman-Cass DA, National Comprehensive Cancer Network. Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network : JNCCN. 2013. PMID: 23667203
Weng KC, Hashizume R, Noble CO, Serwer LP, Drummond DC, Kirpotin DB, Kuwabara AM, Chao LX, Chen FF, James CD, Park JW. Convection-enhanced delivery of targeted quantum dot-immunoliposome hybrid nanoparticles to intracranial brain tumor models. Nanomedicine (London, England). 2013. PMID: 23631502
Komanduri KV. Targeting neovascularization in GVHD. Blood. 2013. PMID: 23620570
Pettitt SJ, Rehman FL, Bajrami I, Brough R, Wallberg F, Kozarewa I, Fenwick K, Assiotis I, Chen L, Campbell J, Lord CJ, Ashworth A. A genetic screen using the PiggyBac transposon in haploid cells identifies Parp1 as a mediator of olaparib toxicity. PloS one. 2013. PMID: 23634208
Boutrus RR, Abi Raad RF, Kuter I, Ancukiewicz M, Roberts L, Solomon N, Ngo T, Borick H, Ryan P, Moy B, Gadd M, Chien J, Younger J, Smith B, Taghian AG, Harris L. Circulating tumor cells as predictors of response and failure in breast cancer patients treated with preoperative chemotherapy. The International journal of biological markers. 2013. PMID: 23015398
Shindo T, Kim TK, Benjamin CL, Wieder ED, Levy RB, Komanduri KV. MEK inhibitors selectively suppress alloreactivity and graft-versus-host disease in a memory stage-dependent manner. Blood. 2013. PMID: 23575444
Rubenstein JL, Wong VS, Kadoch C, Gao HX, Barajas R, Chen L, Josephson SA, Scott B, Douglas V, Maiti M, Kaplan LD, Treseler PA, Cha S, Hwang JH, Cinque P, Cyster JG, Lowell C. CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma. Blood. 2013. PMID: 23570798
Rubenstein JL, Wong VS, Kadoch C, Gao HX, Barajas R, Chen L, Josephson SA, Scott B, Douglas V, Maiti M, Kaplan LD, Treseler PA, Cha S, Hwang JH, Cinque P, Cyster JG, Lowell C. CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma. Blood. 2013. PMID: 23570798
Rubenstein JL, Hsi ED, Johnson JL, Jung SH, Nakashima MO, Grant B, Cheson BD, Kaplan LD. Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013. PMID: 23569323
Rubenstein JL, Hsi ED, Johnson JL, Jung SH, Nakashima MO, Grant B, Cheson BD, Kaplan LD. Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013. PMID: 23569323
Neijenhuis S, Bajrami I, Miller R, Lord CJ, Ashworth A. Identification of miRNA modulators to PARP inhibitor response. DNA repair. 2013. PMID: 23570906
Hussain M, Tangen CM, Berry DL, Higano CS, Crawford ED, Liu G, Wilding G, Prescott S, Kanaga Sundaram S, Small EJ, Dawson NA, Donnelly BJ, Venner PM, Vaishampayan UN, Schellhammer PF, Quinn DI, Raghavan D, Ely B, Moinpour CM, Vogelzang NJ, Thompson IM. Intermittent versus continuous androgen deprivation in prostate cancer. The New England journal of medicine. 2013. PMID: 23550669
Borno HT, Hussein EA, Dudin A, van Aalst JA. Incidence of cleft lip and palate in the palestinian territories: a retrospective study from the Makassed Hospital neonatal unit. The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association. 2013. PMID: 23551076
Maru D, Venook AP, Ellis LM. Predictive biomarkers for bevacizumab: are we there yet? Clinical cancer research : an official journal of the American Association for Cancer Research. 2013. PMID: 23549876